GLYXYN Trademark

Trademark Overview

On Tuesday, January 5, 2021, a trademark application was filed for GLYXYN with the United States Patent and Trademark Office. The USPTO has given the GLYXYN trademark a serial number of 90448135. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, July 23, 2024. This trademark is owned by Biohaven Therapeutics Ltd.. The GLYXYN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, Obsessive Compulsive Disorder (OCD); pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia; none of the aforementioned to include dietary and nutritional supplements or preparations for the treatment of diabetes or related conditions
glyxyn

General Information

Serial Number90448135
Word MarkGLYXYN
Filing DateTuesday, January 5, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, July 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 22, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, Obsessive Compulsive Disorder (OCD); pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia; none of the aforementioned to include dietary and nutritional supplements or preparations for the treatment of diabetes or related conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, April 3, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiohaven Therapeutics Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG
Party NameBiohaven Therapeutics Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew Haven, CT 06510

Trademark Events

Event DateEvent Description
Friday, January 8, 2021NEW APPLICATION ENTERED
Saturday, April 3, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 14, 2021ASSIGNED TO EXAMINER
Friday, July 16, 2021NON-FINAL ACTION WRITTEN
Friday, July 16, 2021NON-FINAL ACTION E-MAILED
Friday, July 16, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, February 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, August 22, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, September 1, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, September 8, 2022ASSIGNED TO PETITION STAFF
Thursday, September 8, 2022CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, October 18, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 5, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 5, 2023SOU EXTENSION 1 FILED
Wednesday, April 5, 2023SOU EXTENSION 1 GRANTED
Friday, April 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 17, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 17, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 12, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 12, 2023SOU EXTENSION 2 FILED
Tuesday, September 12, 2023SOU EXTENSION 2 GRANTED
Thursday, January 25, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 25, 2024SOU EXTENSION 3 GRANTED
Saturday, January 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 1, 2024ASSIGNED TO EXAMINER
Thursday, September 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 25, 2024SOU EXTENSION 3 FILED
Tuesday, July 23, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 23, 2024SOU EXTENSION 4 FILED
Tuesday, July 23, 2024SOU EXTENSION 4 GRANTED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

glyxyn treatment preparations headache pharmaceutical namely disorders ataxia none spinocerebellar disorder